Stay updated on Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.

Latest updates to the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now displays a recruitment status indicating no further participant enrollment. It also adds new user guidance links (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, alongside a version bump to v3.6.0.SummaryDifference0.4%

- Check19 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 in the Study Record Dates, signaling a recent update to the study record.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.4 was released, replacing the previous v3.5.3. This indicates a backend or frontend update for the page, not a change to the visible study details or data.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded 'Multiple myeloma' as a disease focus on the study page. Added a Resources link to Genetic and Rare Diseases Information Center.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Daratumumab combo + Cyclophosphamide Clinical Trial page.